Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent.

Helm PA, Caravan P, French BA, Jacques V, Shen L, Xu Y, Beyers RJ, Roy RJ, Kramer CM, Epstein FH.

Radiology. 2008 Jun;247(3):788-96. doi: 10.1148/radiol.2473070975.

PMID:
18403626
2.

Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.

Spuentrup E, Ruhl KM, Botnar RM, Wiethoff AJ, Buhl A, Jacques V, Greenfield MT, Krombach GA, Günther RW, Vangel MG, Caravan P.

Circulation. 2009 Apr 7;119(13):1768-75. doi: 10.1161/CIRCULATIONAHA.108.826388.

3.

Assessment of myocardial infarction and postinfarction scar remodeling with an elastin-specific magnetic resonance agent.

Wildgruber M, Bielicki I, Aichler M, Kosanke K, Feuchtinger A, Settles M, Onthank DC, Cesati RR, Robinson SP, Huber AM, Rummeny EJ, Walch AK, Botnar RM.

Circ Cardiovasc Imaging. 2014 Mar;7(2):321-9. doi: 10.1161/CIRCIMAGING.113.001270.

5.

Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.

Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M.

Invest Radiol. 2012 Mar;47(3):183-8. doi: 10.1097/RLI.0b013e318236e354.

PMID:
22183078
6.

Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.

Bauner KU, Reiser MF, Huber AM.

Invest Radiol. 2009 Feb;44(2):95-104. doi: 10.1097/RLI.0b013e3181911eab.

PMID:
19077911
7.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653
8.

MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model.

Lee SS, Goo HW, Park SB, Lim CH, Gong G, Seo JB, Lim TH.

Radiology. 2003 Mar;226(3):739-47. Erratum in: Radiology. 2003 Nov;229(2):610.

PMID:
12601203
9.

Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.

Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, Pilgrimm H, Hamm B, Taupitz M.

Radiology. 2006 Jul;240(1):90-100.

PMID:
16684917
10.

Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast.

Weiss CR, Aletras AH, London JF, Taylor JL, Epstein FH, Wassmuth R, Balaban RS, Arai AE.

Radiology. 2003 Mar;226(3):723-30.

PMID:
12616019
11.

Regional contrast agent quantification in a mouse model of myocardial infarction using 3D cardiac T1 mapping.

Coolen BF, Geelen T, Paulis LE, Nicolay K, Strijkers GJ.

J Cardiovasc Magn Reson. 2011 Oct 5;13:56. doi: 10.1186/1532-429X-13-56.

12.

Sequential analysis of infarcted and normal myocardium in piglets using in vivo gadolinium-enhanced MR images.

van Dijkman PR, Höld KM, van der Laarse A, Holman ER, Ozdemir HI, van der Nat TH, de Roos A, van der Wall EE.

Magn Reson Imaging. 1993;11(2):207-18.

PMID:
8455431
14.
15.

Myocardial fat deposition after left ventricular myocardial infarction: assessment by using MR water-fat separation imaging.

Goldfarb JW, Roth M, Han J.

Radiology. 2009 Oct;253(1):65-73. doi: 10.1148/radiol.2532082290.

PMID:
19703860
16.

Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study.

Nijveldt R, Hofman MB, Hirsch A, Beek AM, Umans VA, Algra PR, Piek JJ, van Rossum AC.

Radiology. 2009 Feb;250(2):363-70. doi: 10.1148/radiol.2502080739. Erratum in: Radiology. 2009 May;251(2):615.

PMID:
19164698
17.

Occlusive myocardial infarction: investigation of bis-gadolinium mesoporphyrins-enhanced T1-weighted MR imaging in a cat model.

Choi SH, Lee SS, Choi SI, Kim ST, Lim KH, Lim CH, Weinmann HJ, Lim TH.

Radiology. 2001 Aug;220(2):436-40.

PMID:
11477248
18.

Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model.

Choi SI, Choi SH, Kim ST, Lim KH, Lim CH, Gong GY, Kim HY, Weinmann HJ, Lim TH.

Radiology. 2000 Jun;215(3):863-8.

PMID:
10831712
19.

MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.

Dulce MC, Duerinckx AJ, Hartiala J, Caputo GR, O'Sullivan M, Cheitlin MD, Higgins CB.

AJR Am J Roentgenol. 1993 May;160(5):963-70.

PMID:
8470611
20.

Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging.

Petersen SE, Mohrs OK, Horstick G, Oberholzer K, Abegunewardene N, Ruetzel K, Selvanayagam JB, Robson MD, Neubauer S, Thelen M, Meyer J, Kreitner KF.

J Cardiovasc Magn Reson. 2004;6(2):541-8.

PMID:
15137338
Items per page

Supplemental Content

Support Center